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ABSTRACT 
Tobacco smoking is the common practice in a large percentage of the population worldwide, 
and the incidence is continuously increasing. Tobacco smoking is the most preventable cause 
of lung cancer, and it also impairs oral health. People are aware of the carcinogenic effects of 
tobacco smoking on the lungs and oral cavity, but it is also a risk factor for many other harm-
ful diseases. This review article covers most of the diseases that are associated with tobacco 
smoking, such as coronary artery disease (CAD), diabetes, chronic obstructive pulmonary 
disease (COPD), arthritis, impotency, infertility, tuberculosis, and Alzheimer’s disease. The 
association of these diseases with tobacco smoking is discussed in detail in this review, along 
with their possible pathophysiology. This article focuses on the ongoing research of these dis-
eases, and aims to raise awareness of the hazards of tobacco smoking, and to promote anti-
smoking awareness programs. 
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INTRODUCTION 
The number of the cigarette smoker in 
the world is estimated at 1.3 billion, and 
this figure is expected to rise to 1.7 billion 
by 2025. Every second smoker will die of a 
tobacco-caused disease (WHO, 2003). To-
bacco smoking causes lung cancer as well 
as it is an etiologic factor for several other 
cancers of the different organs and for the 
impaired oral health. It is a strong risk fac-
tor for many other diseases like cardiovas-
cular diseases (CVD), coronary artery dis-
ease (CAD), diabetes, chronic obstructive 
pulmonary disease (COPD), arthritis, impo-
tency, infertility, tuberculosis, Alzheimer’s 
disease, etc. (Table 1). There are three ma-
jor constituents of tobacco smoke like nico-
tine, Co, oxidants and harmful gases, which 
create a problem for human health. Tobacco 
smoking induced all diseases are discussed 
here along with their possible pathophysi-
ologies. 
 
Table 1: Tobacco smoking associated diseases 
• Cardiovascular Diseases (CVD) 
Coronary artery diseases (CAD) 
Cerebrovascular diseases (Stroke) 
Abdominal Aortic Aneurysm (AAA) 
Peripheral Vascular disease (PVD) 
(Buerger’s Disease) 
• Chronic Obstructive Pulmonary  
Disease (COPD) 
Chronic Bronchitis 
Emphysema 
• Diabetes 
• Tuberculosis 
• Rheumatoid Arthritis (RA) 
• Infertility 
• Impotency 
• Alzheimer’s Disease (AD) 
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CARDIOVASCULAR DISEASES 
(CVD) 
The association between smoking and 
cardiovascular disease (CVD) was first 
pointed out in 1950 (Hammond and Horn, 
1958). CVD is a group of several diseases, 
such as coronary artery disease, cere-
brovascular disease (stroke), abdominal 
aortic aneurysm (AAA), peripheral vascular 
disease, which are associated with the 
chronic tobacco smoking (Bišanović et al., 
2011). Cigarette smoking is a major inde-
pendent risk factor for CVD. While the as-
sociation among chronic smoking and car-
diovascular disease is well established, the 
pathophysiology is still not completely un-
derstood (Talukder et al., 2011). 
 
• Coronary Artery Disease (CAD) 
Smoking predisposes individuals to 
atherosclerotic syndromes like coronary 
artery syndromes, myocardial infarction, 
stable angina and sudden death. The risks 
of coronary artery disease (CAD) are great-
est in heavy smokers who have the longest 
duration of smoking (Burns, 2003). The 
relative rate of death from CAD in smokers 
is 70 % higher than non-smokers and deaths 
are even high, with 20 % in chronic and 
heavy smokers who have up to 15 cigarettes 
per/day (US Department of Health and 
Human Services, 1983). 
Major components of tobacco smoke 
are: nicotine, CO, oxidants (per-oxides, ni-
trates, etc.) and harmful gases (Hammond 
et al., 1958; Benowitz, 2003) [Figure 1]. 
These components damage the endothelial 
cells, so the endothelial damage is the first 
step for the atherosclerotic development 
(Noronha et al., 1993; Lehr et al., 1993; 
Booyse et al., 1981; Boyle et al., 1997; Be-
nowitz, 2003). Chemical oxidant toxicity 
disturbs the normal secretion of nitric oxide 
(NO), which is responsible for the vasodila-
tory functions of the endothelium from the 
endothelial cells (Boyle et al., 1997; Celer-
majer et al., 1996;Stafford et al., 1996; 
Higman et al., 1993; Kiowski et al., 1994). 
There is an important role played by the 
interaction between inflammatory cytokines 
and tobacco smoke constituents in the in-
duction of endothelial dysfunction (Barbieri 
et al., 2011). It results in the impaired re-
lease of NO from the endothelium, causing 
the loss of coronary vasodilation (Leone, 
2010). So, the regulatory functions of NO, 
like inflammation, leukocyte adhesion, 
platelet activation, thrombosis get impaired; 
these steps form an atheroma condition (Ta-
lukder et al., 2011; Pettiti and Kipp, 1986; 
Kool et al., 1993). A study suggests that the 
platelet activation is a link in the patho-
physiology of diseases prone to thrombosis 
and inflammation. High mean platelet vol-
ume (MPV) is associated with a low grade 
inflammatory condition, leading to arterial 
and venous thromboses (Gasparyan et al., 
2011). In contrast, smokers have higher 
levels of neutrophils and activated mono-
cytes, resulting increased level of macro-
phages (Gasparyan et al., 2011). These also 
play an important role for the endothelial 
damage (Boyle et al., 1997), so the endo-
thelium-derived nitric oxide (NO) plays a 
major role in the regulation of structure, 
function and endothelial dysfunction, which 
could be considered the first step in the 
pathogenesis of atherosclerosis (Grassi et 
al., 2010). Irregular inflammation leads to 
the disruption of the atherosclerotic plaques 
causing ruptured plaques and thrombosis 
(Lehr et al., 1993) [Figure 2]. Nicotine af-
fects the hemodynamic parameter of the 
heart, increasing heart rate and smoking 
mediated blood pressure (Nicod et al., 
1984). Atherosclerosis causes myocardial 
infarction and stroke. Nicotine mediates the 
release of adrenal catecholamine, which 
causes increased heart rate by lowering the 
coronary blood flow that increases myocar-
dial contractibility, then the heart demands 
more oxygen, which may lead to myocar-
dial ischemia. (Cryer et al., 1976; Laustiola 
et al., 1988). Adrenaline also causes high 
blood pressure, the most common risk fac-
tor for coronary heart disease. Nicotine in-
duced catecholamine, promotes lypolysis 
and release of fatty acids that are converted 
into VLDL by the liver (Hellerstein et al., 
1994) increasing serum LDL (bad choles-
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terol) and decreasing the levels of HDL 
(good cholesterol) (Fortman et al., 1986; 
Stone and Thorpe, 1985). Carbon mono-
oxide (CO2) has a strong affinity for hemo-
globin (Hb) (Turner et al., 1986). Thus, the 
oxygen carrying capacity of the blood to the 
heart gets lowered. Due to an insufficient 
amount of O2 to the heart, myocardial me-
tabolism gets disturbed resulting in exces-
sive heart work, leading to the MI (Garland 
et al., 1985), indicating that the angina pec-
toris is mostly precipitated by hemody-
namic factors (Haerem et al., 1974).  
Cigarette Smoke
Constituents
Nicotine
Carbon mono-
oxide (CO)
Oxidants
Free Radicals
Cigarette
Carcinogens Harmful gases
Figure 1: Tobacco smoke constituents 
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Figure 2: A possible pathophysiology of tobacco smoke induced cardiovascular disease (car-
diovascular dysfunction) 
Oxidants/anti-oxidants, radicals & other harmful contents of tobacco smoke activate the neutrophil, 
monocyte, platelets, T-cell induces cytokine activation leading to inflammation. Contents of tobacco 
smoke create oxidative stress which impairs the normal function of NO like (Impaired vasodilatory 
function, endothelial dysfunction, inflammation, leukocyte, platelet activation, thrombolysis & fibrolytic 
factor); all these events are affected leading to atheroma condition which further leads to atherothrom-
botic disease. 
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• Cerebrovascular disease 
In the case of cerebrovascular disease, 
stroke mainly has been shown to be associ-
ated with the tobacco smoking (Nicotine) 
(Mazzone et al., 2010). In stroke a man los-
es his/her thinking ability/movement/ 
speech and the senses. Smokers have dou-
ble risk of strokes than never smokers. 
Smoking associated risk of stroke may be 
associated with the atherogenic effects or 
high blood pressure (Mazzone et al., 2010). 
According to a recent study on the hippo-
campus, nicotine impairs estrogen receptor-
mediated phosphorylation of a cyclic-AMP 
element binding protein, an event necessary 
for neuronal survival and also exacerbates 
ischemic damage (Raval et al., 2011). 
 
• Abdominal Aortic Aneurysm (AAA) 
Tobacco smoking is the important risk 
factor for AAA (Nordon et al., 2011, Stolle 
et al., 2010). Atherosclerosis in the ab-
dominal aortic region increases the risk of 
the aneurysm in the abdominal aortic region 
leading to AAA (Burns, 2003). Death rate 
is 2-3 times higher in those who quit smok-
ing than a never smoker (Hajek et al., 
2002). Atherosclerosis is the precursor for 
AAA. Aortic aneurysm in an animal model 
shows smooth muscle cell density de-
creased in medial layer with increased p53 
(Holmes et al., 1996), smoking is also re-
lated to the inactivation of the alpha 1-anti 
trypsin leading to the theory that the inhibi-
tion of alpha 1-anti trypsin may lead to 
AAA (Starpetti et al., 1987). A recent study 
suggests that the formation and severity of 
the AAA in hypertensive apolipoprotein E 
[ApoE(-/-)] mice are accelerated by expo-
sure to the mainstream smoke and the ma-
trix metalloproteinases (MMP)-2, -3, -8, -9, 
and -12 in the abdominal aortas are highly 
expressed in angiotensin (Ang II) treated 
mice together with smoke exposure. And 
the proteolytic activity of MMP-2 and 
MMP-9 was also enhanced in Ang II-
treated mice exposed to tobacco smoke 
(Nordon et al., 2011). 
• Peripheral Vascular Disease (PVD) 
Tobacco smoking (nicotine) is a very 
important risk factor for PVD, mainly Buer-
ger’s disease or thromboangiitis obliterans 
(Highlander et al., 2011) in younger smok-
ers and it becomes symptomatic through 
claudication, rest pain, ulcers and gangrene 
(Lawrence et al., 2008; Quintas and Albu-
querque, 2008). This disease is an inflam-
matory occlusive disorder, which causes 
swelling of the small and medium-sized ar-
teries (sometimes the veins) in the feet and 
legs (Highlander et al., 2011). It is more 
common in young smokers especially aged 
20 to 40. It’s a narrowing of arteries in the 
extremities caused by blocked arteries, 
which reduce blood circulation mainly oc-
curs in leg and feet causing pain while 
walking and resting (Buerger’s Disease) 
(Winstanley et al., 1995). Nine out of ten 
people with this disease are smokers. This 
disease is associated with atherosclerosis. 
In another word, atherosclerosis might be a 
primary consequence in the development of 
PVD (Constans et al., 2010). Moreover, the 
Buerger’s disease and atherosclerosis may 
be associated with the endothelial dysfunc-
tion (Idei et al., 2011). 
 
Tobacco smoking and chronic  
obstructive pulmonary disease (COPD) 
Smoking is the major cause of COPD. 
Approx. 80-90 % of COPD is caused due to 
smoking (Sethi et al., 2000). Tobacco 
smoke increases the risk of dying from 
COPD by ten times (Kim et al., 2011, 
Streck et al., 2010). About 50 % of COPD 
patients are active cigarette smokers (van 
Dijk et al., 2010). Several destructive proc-
esses are involved in the pathobiology of 
COPD, including: inflammation, extracellu-
lar matrix destruction (protease and anti-
protease imbalance) and oxidative stress 
(oxidant and anti-oxidant imbalance). To-
bacco smoking is strongly associated with 
COPD. In the case of COPD lung com-
partments mainly involve diseases relating 
to airway (chronic bronchitis) and paren-
chymatous destruction (emphysema) (Fer-
rara, 2011; Sethi and Rochester, 2000). 
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Cigarette smoke contains approximately 
(10)17 oxidant molecules (per-oxides, NO) 
per puff (Pryor et al., 1993). Chronic oxida-
tive stress caused by cigarette smoking, in-
duces mucus secretion and inhibits cystic 
fibrosis transmembrane conductance regu-
lator function. The increased mucus viscos-
ity renders the airways susceptible to bacte-
rial infections, a hallmark of chronic bron-
chitis (Cantin, 2010). Due to oxidative 
stress alveolar macrophages get activated 
and release neutrophil chemotactic factors 
(Praticò et al., 1998) such as LTB4, IL-8 
(Keatings et al., 1996; Zakrzewski et al., 
1987). Then these inflammatory cells re-
lease proteases (MMPs, neutrophil elastase) 
(Shapiro, 1994). By stimulating CD+8Th 
cells, it releases chemokines (IFN-γ, IL-4, 
IL-13) and perforins (Barnes, 1996). Neu-
trophil elastase proteolyses the alveolar 
elastin, leading to alveolar wall destruction 
causing emphysema and mucus hyper-
secretion, which is a prominent feature of 
COPD (Finkelstein et al., 1995). Neutrophil 
elastase and MMPs accounts for most of the 
protease and anti-protease imbalances in 
COPD. α -1 anti-trypsin is the inhibitor of 
neutrophil elastase, but individuals are most 
susceptible to emphysema if they have a 
congenital deficiency of α-1 anti-trypsin 
[Figure 3] (Stoller and Aboussouan, 2005). 
Several genomic studies regarding smoking 
associated COPD are under investigation. 
According to (Sood et al., 2010) there is a 
link between wood smoke exposure and 
aberrant promoter methylation of the p16, 
or GATA4 genes, which synergistically in-
crease the risk for reduced lung function in 
cigarette smokers. Another study by Ishii et 
al. (2011) proposes that a serotonin trans-
porter gene, SLC6A4, is thought to be re-
lated to nicotine dependence and depres-
sion, which is one of the comorbidity of 
chronic obstructive pulmonary disease 
(COPD). 
 
SmokeCigarette
Oxidative stress
(Alveolar macrophage)
(Neutrophil)
LTB4, IL‐8
Proteaseα‐ 1 anti trypsin
(Protease Inhibitor)
Inhibited
CD+ 8 Th cell
IL‐4, IFN‐γ,IL‐13
Perforins
Releases
Alveolar wall destruction
Emphysema
Hyper mucus‐secretion
Chronic Bronchitis
MMPs, Neutrophil  elastase
Figure 3: A possible mechanism of tobacco 
smoke induced Chronic Obstructive Pulmo-
nary Disease (COPD): Oxidants of tobacco 
smoke activate the alveolar macrophages that 
activate neutrophils and also release neutrophil 
chemotactic factors like IL-8, LTB4, then the 
neutrophils release protease that breaks down 
the tissues in the lung causing emphysema 
leading to chronic mucus hypersecretion 
(chronic bronchitis). Activity of protease inhibitor 
(α-1 anti-trypsin) gets impaired. CD+8 cells may 
also be involved in this cascade. 
 
Tobacco smoking and diabetes 
Cigarette smoking is an independent 
modifiable risk factor for development of 
diabetes (Zhang et al., 2011; Jee et al., 
2010; XIE et al., 2009). 50 % of smokers 
are more likely to develop diabetes com-
pared to non-smokers (American Council 
on Science and Health, 2007). Smoking has 
been identified as a risk factor for insulin 
resistance, which can lead to diabetes type-
2 (insulin-independent). In a type-2 diabe-
tes the body does not produce enough insu-
lin or insulin produced by the body does not 
work properly hence called insulin resis-
tance. Cigarette smoke damages blood ves-
sels, which impair insulin sensitivity by re-
ducing the blood flow in muscle tissue 
(Reaven and Tsao, 2003; Targher et al., 
1997). Diabetes is associated with several 
other further clinical problems like reti-
nopathy, gangrene, kidney failure and 
blindness. Tobacco smoking can make all 
these problems worse (Targher, 2005; Utah 
Department of Health, 26 September 2007), 
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although the exact mechanism is still not 
fully understood. 
 
Tobacco smoking and tuberculosis (TB) 
Association between tobacco smoking 
and tuberculosis was first observed in 1918 
(Webb, 1918; WHO, 2003). Active smok-
ing is significantly associated with TB in-
fection and disease (Leung et al., 2010) 
(Wen et al., 2010) while second hand smok-
ing is associated with tuberculosis infec-
tions in children and younger people 
(Leung et al., 2010). Up to one in five 
deaths from TB could be avoided if patients 
were not smokers (Tobacco & Tuberculosis 
Fact sheet 07). Tobacco smoking is the 
solid etiological factor for the accelerated 
decline in the lung function (Ross et al., 
2010). Pathophysiology of tobacco smoking 
associated TB may be related to the several 
possible mechanisms, such as impairment 
in the immune response, CD4 lymphopenia 
(Altet et al., 1996), hormonal imbalances, 
disruption of cilia function (Buskin et al., 
1994), morphological and functional chan-
ges in alveolar macrophages (Davies et al., 
2006), so it may be a causal factor for an 
individual to be easily infected with myco-
bacterium tuberculosis leading to pulmo-
nary tuberculosis. However, the exact 
pathophysiology of smoking associated tu-
berculosis is still not well understood. 
 
Tobacco smoking and arthritis (RA) 
Cigarette smoking is a solid risk factor 
for rheumatoid arthritis (RA) (Källberg et 
al., 2011; Okamoto et al., 2011; Sugiyama 
et al., 2010). Cigarette smoke produces sev-
eral oxidants (super-oxides, hydroxyl ion, 
etc.), which create oxidant and anti-oxidant 
imbalance that may activate redox sensitive 
transcription factor such as NF-kB, which 
in turn reduces the glutathione level 
(Nguyen et al., 2003). Glutathione (GSH), 
an anti-oxidant helps protect cells from 
ROS such as free radicals and peroxides 
(Pompella et al., 2003). Nicotine alters 
macrophage function (pinocytosis, endocy-
tosis, microbial killing and reducing TNF-α 
secretion induced by LPS) (Green and 
Carolin, 1967). Synovial cells possess aro-
mated hydrocarbon receptors for polycyclic 
aromatic hydrocarbons (PAHs) released 
from tobacco smoking, after the binding of 
PAHs to AhRs on synovial fibroblast-like 
cells; these cells release several pro-
inflammatory cytokines and chemokines in 
excess like 1L-1α, IL-1β, IL-6, IL-8 and 
CCR20. IL-1 and IL-6 induces differentia-
tion of Th17 cells, which finally releases 
1L-17, then induces IL-1, IL-6 and TNF-α 
release from macrophages (Onozaki, 2009). 
Tobacco smoking decreases the levels of 
anti-inflammatory cytokines, such as IL-10 
(Arnson et al., 2010). This acute inflamma-
tory reaction leads to chronic inflammation 
under the influence of genetic factors, hor-
mones leading to RA. (Itoh et al., 2007a, b) 
[Figure 4]. According to a study, high-
grade inflammatory diseases associate with 
active rheumatoid arthritis (Gasparyan et 
al., 2011). PAD2 and PAD4, genes encod-
ing (Peptidyl Arginine Deiminase) are ex-
pressed in the synovium of RA patients 
(Foulquier et al., 2007; Dong et al., 2007) 
whereas PAD4 is highly expressed in the 
synovium and found to be associated with 
the development of RA. PAD4 is an estro-
gen dependent (Buchan et al., 1988) while 
smoking has anti-estrogenic effects through 
the formation of inactive 2-hydroxy catechu 
estrogens (Baron et al., 1990), which would 
counteract PADs. Tobacco smoke increases 
the risk of citrullination that is catalyzed by 
PAD enzyme. These citrullinated antigens 
may be helpful for exploring the pathogenic 
mechanisms. Antibodies to the citrullinated 
proteins are present in HLA ‘shared epi-
tope’ alleles (SE) positive patients (Goeld-
ner et al., 2011; Wegner et al., 2010). It was 
observed that without any treatment smok-
ers are affected by osteoarthritis (OA) leu-
kocytosis (biomarker of cardiovascular 
risk) (Bartolone et al., 2010). 
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Figure 4: A possible pathophysiology of tobacco smoke induced rheumatoid arthritis (RA). 
Oxidants from tobacco smoke activate the transcription factor NF-κB which decreases the level of glu-
tathione, then reactive oxygen species (ROS) level increases leading to Inflammation. In detail to-
bacco smoke activates pro-inflammatory cytokines and chemokines mediated by the binding of poly-
cyclic aromatic hydrocarbon (PAHs) to the aromatic hydrocarbon receptors on synovial cells, then 
these cytokines and chemokines induce T-helper 17 cells (Th17) Th17 cells induces IL-17, then the IL-
17 induces IL-1, IL-6, and TNF-α production from macrophage. Now the acute inflammation process 
leads to chronic inflammation under the effects of several factors like hormones, genetic factors. 
 
 
 
Tobacco smoking and impotency 
Tobacco smoking impairs the erection 
of the penis, causing erectile dysfunction 
ED, which leads to impotency (Chan et al., 
2010). It has been noticed that penile blood 
flow in smokers is lower than non-smokers, 
which is the main cause of impotency (Ro-
sen et al., 1991; Condra et al., 1986,). Use 
of tobacco smoke may increase the likeli-
hood of moderate or complete ED by at 
least two-fold and heavy smokers are more 
likely to be impotent (Mirone et al., 2002; 
McVary et al., 2001). Smoking predisposes 
smokers to arterial risk factors causing 
atherosclerosis by damaging the vessels 
(Enevoldsen et al., 2011; Jiang et al., 2010). 
Atherosclerotic changes increase the sus-
ceptibility of impotency to the smokers 
(Odriozola et al., 2010). However, the exact 
pathophysiology of smoking associated im-
potency is still unclear (McVary et al., 
2001). 
 
Tobacco smoking and male infertility 
Smoking is associated with men’s infer-
tility by affecting the sperm production, 
motility, morphology and spermatogenesis 
(Monoski et al., 2002). Smoke-induced tox-
ins primarily hamper sperm motility and 
seminal fluid quality causing asthenozoo-
spermia (Gaur et al., 2010). Tobacco smok-
ing impairs the sperm DNA integrity and 
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nuclear maturation (Niu et al., 2010). CO, 
nicotine, polycyclic aromatic hydrocarbons 
and other oxidants cause oxidative damage, 
which further damage DNA in spermatozoa 
(Shen et al., 1997). Tobacco smoking also 
affects seminal plasma leucocytes then; it 
generates excess free oxygen radicals, 
which may cause sperm DNA fragmenta-
tion (Koskimies et al., 2010). Nicotine con-
tent in tobacco smoke also seems to be a 
potent factor that can alter the fertility po-
tential of man by inducing the membrane 
impairments, altering the GSH metabolism 
cycle, changing the sperm morphology and 
motility, and also by inducing the DNA 
fragmentation (Arabi and Shareghi, 2005). 
The extent of oxidative damage among 
smokers was associated with the decrease in 
anti-oxidants defenses in the sperm of infer-
tile males (Pasqualotto et al., 2008). Oxida-
tive stress by cigarette smoking may have 
significant inverse effect on the protamine 1 
(P1) and 2 (P2), a nuclear protein necessary 
for proper sperm chromatin condensation 
and subsequent male fertility (Hammadeh 
et al., 2010). The oxidants of tobacco 
smoke lower the zinc level that is required 
for the sperm chromatin stability in the se-
men of smokers (Liu et al., 2010). Serum 
estradiol (E2) and prolactins are increased 
in smokers as compared to non-smokers 
(Attia et al., 1989). Estradiol impairs sper-
matogenesis, E2 level increases catechola-
mine level, which produces ischemia of 
seminiferous tubules (Klaiber and Brover-
man, 1988). A dose response relationship is 
found between smoking and testosterone. 
Luteinizing hormone (LH) and the LH free 
testosterone ratios were observed (Ramlau-
Hansen et al., 2007). According to Kapoor 
and Jones (2005) smoking adversely affects 
the testosterone level due to changes in 
plasma-binding capacity than the direct ef-
fect of nicotine on androgens. 
 
Tobacco smoking and  
Alzheimer’s disease (AD) 
Tobacco smoking is a modifiable risk 
factor for Alzheimer’s disease (Rusanen et 
al., 2011). Heavy smoking almost doubled 
the risk of AD (Ott et al., 1998). Alz-
heimer’s disease is a brain neurodegenera-
tive disorder causing dementia, memory 
loss, disability, impairment of intellectual 
function (Fratiglioni and Wang, 2000). 
Vascular risk factor of an individual, such 
as hypertension, high blood pressure, 
atherosclerosis, arterial fibrillation, stroke at 
a time of current AD impacts on the rate of 
progression of AD (Mielke et al., 2007).  
However, the risk of CVD is a major risk 
factor for AD (Lightwood et al., 2001). To-
bacco smoking induces oxidant and anti-
oxidant imbalance creating oxidative stress 
leading to inflammation causing tissue in-
jury (Isik et al., 2007; Burke and Fitzgerald, 
2003). ROS (Reactive oxygen species) gen-
erations cause neurodegeneration within the 
brain tissues because the brain is the more 
susceptible to oxygen free radical damage 
(Polidori et al., 2007). Midlife smoking is 
associated with an increased risk of demen-
tia and AD later in life only among those 
individuals carrying the apolipoprotein 
(APOE ε4 allele) (Rusanen et al., 2010), 
although the pathophysiology of smoking 
related AD remains to be elucidated. 
 
CONCLUSION 
Tobacco smoking is pandemic. Besides, 
the impaired oral health and malignancy, it 
is the cause of several chronic and harmful 
diseases. Long term cigarette exposure, 
whether active or passive also makes a per-
son more susceptible to easily get devel-
oped various diseases like cardiovascular 
diseases, diabetes, tuberculosis, chronic ob-
structive pulmonary disease (COPD), impo-
tency, infertility, Alzheimer’s disease, ar-
thritis, etc. Tobacco smoking induced athe-
rosclerotic syndromes are the precursor for 
cardiovascular diseases like coronary artery 
syndromes (myocardial infarction, stable 
angina, and sudden death), cerebrovascular 
disease, abdominal aortic aneurysm, and 
peripheral vascular disease, diabetes and 
impotency. There is a major role of smok-
ing induced oxidants and anti-oxidants im-
balance in causing the COPD, arthritis and 
tuberculosis. In case of COPD, MMPs, neu-
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trophil elastase, and α-1 anti-trypsin should 
be mainly focused to reveal the exact pa-
thophysiology of smoking induced COPD. 
Tobacco smoking is the solid etiological 
factor for the accelerated decline in the lung 
function, so it may be a causal factor for an 
individual to be infected with mycobacte-
rium tuberculosis leading to pulmonary tu-
berculosis. It might be a possible hypothesis 
for the smoking induced tuberculosis. How-
ever, there is a conflict in case of smoking 
associated Alzheimer’s disease, most of the 
studies are in favor of smoking induced 
AD, but some are not. To overcome with 
this problem, a long term follow-up study 
should be done. Nicotine replacement ther-
apy should be encouraged for smoking ces-
sation. Smoker awareness programmes re-
garding all these diseases should be con-
ducted as well as the anti-smoking adver-
tisement must be made and promoted 
worldwide. Participants in our scientific 
research trial should be rewarded; it will be 
helpful to motivate the smokers to be in-
cluded in our research. 
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